{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:09:49Z","timestamp":1787497789779,"version":"build-2736575974"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The promotion and application of ART have significantly reduced the mortality rate of AIDS patients in China, but the problem of LLV that follows cannot be ignored. LLV is closely associated with viral failure and increased all-cause mortality. Conducting a systematic study on the prevalence of LLV among PLWH in China and its influencing factors has significant clinical implications for the comprehensive management, effective prevention, and intervention of LLV in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies were included if research subjects were PLWH in China, with a duration of ART treatment of \u22656\u202fmonths, the research types were cohort studies, case\u2013control studies, and cross-sectional studies, the primary outcome indicator was LLV occurrence, as well as research findings were disseminated in Chinese or English. The systematic review was conducted using the R studio software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our review included a total of 20 original studies, covering 225,687 HIV\/AIDS patients, among which 45,265 were LLV. Our study showed that the overall prevalence rate of LLV among PLWH in China was 10.6% (95% CI: 6.8%\u202f~\u202f16.1%). Further subgroup analysis revealed that Blip was higher than pLLV, the prevalence of LLV was the highest in the VL range of 50\u202f~\u202f199 cp\/mL; there were no significant differences in the prevalence of LLV among different regions, type of study and ART regimens. The analysis of factors influencing LLV showed that poor ART adherence, baseline VL\u202f&amp;gt;\u202f10\n                      <jats:sup>5<\/jats:sup>\n                      cp\/mL, changing the treatment schemes, baseline CD4\u202f&amp;lt;\u202f350 cells\/\u03bcL, PI-based regimen at initiation, age \u226550\u202fyears, and age of ART initiation \u226550\u202fyears were risk factors for LLV among PLWH, while homosexual transmission was a protective factor for LLV (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of LLV among PLWH was moderate to low in China. Special attention should be paid to older population with PLWH who had poor ART adherence, high baseline VL, had changed the treatment schemes, had a low baseline CD4 level, had an PI-based regimen at initiation, started ART relatively late, and needed enhanced compliance management and drug resistance testing, as well as increased VL testing frequency to avoid adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251047912<\/jats:uri>\n                      , identifier (CRD420251047912).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1661253","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:31:27Z","timestamp":1759383087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of low-level viremia and related influencing factors among people living with HIV in China: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref1","article-title":"Global HIV statistics fact sheet 2024","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.13419\/j.cnki.aids.2025.03.01","article-title":"National AIDS and STD epidemic situation in December 2024","volume":"31","year":"2025","journal-title":"Chin J AIDS STD"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/QAD.0000000000003881","article-title":"Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial","volume":"38","author":"Crowell","year":"2024","journal-title":"AIDS"},{"key":"ref4","article-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV","year":"2024"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.16505\/j.2095-0136.2025.0001","article-title":"Chinese guidelines for the diagnosis and treatment of AIDS (2024 edition)","volume":"15","author":"Shen","year":"2025","journal-title":"Chin J Viral Dis"},{"key":"ref6","article-title":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring:recommendations for a public health approach","year":"2021"},{"key":"ref7","first-page":"57","volume-title":"National Free Antiretroviral Therapy Manual for AIDS (5th edition)","year":"2023"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/ciac762","article-title":"Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort","volume":"76","author":"Elvstam","year":"2023","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12929-024-01064-z","article-title":"Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era","volume":"31","author":"Lara-Aguilar","year":"2024","journal-title":"J Biomed Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"ofae147","DOI":"10.1093\/ofid\/ofae147","article-title":"Low level viremia is associated with serious non-AIDS events in people with HIV","volume":"11","author":"Ganesan","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/hiv.13320","article-title":"Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: a retrospective cohort study","volume":"24","author":"Yu","year":"2023","journal-title":"HIV Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciaa413","article-title":"All-cause mortality and serious non-AIDS events in adults with low-level human immunodeficiency virus viremia during combination antiretroviral therapy: results from a Swedish Nationwide observational study","volume":"72","author":"Elvstam","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.13419\/j.cnki.aids.2023.03.01","article-title":"Analysis of the epidemic situation of AIDS in China and prospects for prevention and control","volume":"29","author":"Han","year":"2023","journal-title":"Chin J AIDS STD"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12879-020-4837-y","article-title":"Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.7661\/cjim.20230628.272","article-title":"Construction of a clinical evidence grading system for traditional Chinese medicine intervention based on the principles of evidence-based medicine","volume":"43","author":"Liu","year":"2023","journal-title":"Chin J Integr Tradit West Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref18","volume-title":"Research on the current situation and influencing factors of low viral load in HIV\/AIDS patients after HAART in Dali area. (master\u2019s thesis)","author":"Zhang","year":"2023"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.16190\/j.cnki.45-1211\/r.2022.04.028","article-title":"Analysis of the incidence and influencing factors of low viral load in HIV-infected individuals in Guigang City, Guangxi","volume":"39","author":"Wang","year":"2022","journal-title":"J Guangxi Med Univ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.13419\/j.cnki.aids.2022.10.16","article-title":"Analysis of HIV-1 genotypic resistance characteristics in patients with low viral load after antiviral therapy","volume":"28","author":"L\u00fc","year":"2022","journal-title":"Chin J AIDS STD"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3969\/j.issn.1002-1310.2022.05.001","article-title":"Research on the influencing factors and clinical significance of HIV low viral load","volume":"44","author":"L\u00fc","year":"2022","journal-title":"J Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.13604\/j.cnki.46-1064\/r.2024.12.13","article-title":"Analysis of the occurrence and influencing factors of low viral load in HIV\/AIDS patients of different ages in Zhengzhou City","volume":"24","author":"Li","year":"2024","journal-title":"Chin Trop Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3784\/jbjc.202303010079","article-title":"Analysis of the occurrence and influencing factors of low viral load in HIV\/AIDS patients in Henan Province","volume":"38","author":"Ji","year":"2023","journal-title":"Dis Surveill"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3969\/j.issn.1006-2483.2022.06.021","article-title":"Association and influencing factors of low viral load and failure of viral suppression in HIV-infected individuals in Hubei Province","volume":"33","author":"Guo","year":"2022","journal-title":"Public Health Prev Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.12183\/j.scjpm.2024.1109","article-title":"Analysis of the occurrence and influencing factors of low viral load in HIV\/AIDS patients receiving antiviral treatment in Lu'an City","volume":"50","author":"Chen","year":"2024","journal-title":"South China Prev Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.11847\/zgggws1132975","article-title":"Analysis of the occurrence of HIV low viremia in antiviral treatment for AIDS in Yunnan Province","volume":"38","author":"An","year":"2022","journal-title":"Chin J Public Health"},{"key":"ref27","volume-title":"Research on the influencing factors of HIV-1 low viral load in Hunan Province and analysis of the risk of developing drug resistance. (master\u2019s thesis)","author":"Zhang","year":"2023"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3760\/cma.j.cn311365-20220623-00267","article-title":"Analysis of risk factors for low viral load in patients with HIV\/AIDS undergoing antiviral therapy","volume":"41","author":"Wen","year":"2023","journal-title":"Chin J Infect Dis"},{"key":"ref29","volume-title":"Clinical significance of low viral load in AIDS patients after antiviral treatment. (master\u2019s thesis)","author":"Li","year":"2019"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/hiv.13251","article-title":"Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: a retrospective cohort study in Beijing, China","volume":"23","author":"Bai","year":"2022","journal-title":"HIV Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"106631","DOI":"10.1016\/j.ijantimicag.2022.106631","article-title":"Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens","volume":"60","author":"Chen","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/hiv.13250","article-title":"Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: a prospective cohort study","volume":"23","author":"Ding","year":"2022","journal-title":"HIV Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jgar.2022.02.007","article-title":"Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy","volume":"29","author":"Hsu","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12879-023-08906-5","article-title":"Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study","volume":"24","author":"Lao","year":"2024","journal-title":"BMC Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.2147\/IDR.S332924","article-title":"Persistent low-level viremia is an independent risk factor for Virologic failure: a retrospective cohort study in China","volume":"14","author":"Li","year":"2021","journal-title":"Infect Drug Resist"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1451201","DOI":"10.3389\/fmicb.2024.1451201","article-title":"Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.16505\/j.2095-0136.2024.0109","article-title":"General Office of the State Council of the People\u2019s Republic of China. China's plan for controlling and preventing AIDS (2024 - 2030)","volume":"15","year":"2025","journal-title":"Chin J Virol Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2447613","DOI":"10.1080\/22221751.2024.2447613","article-title":"The prevalence of low-level viraemia and its association with virological failure in people living with HIV: a systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/hiv.12134","article-title":"Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals","volume":"15","author":"Zoufaly","year":"2014","journal-title":"HIV Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation","volume":"57","author":"Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e1815-e1824","DOI":"10.1016\/S2214-109X(22)00413-2","article-title":"Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study","volume":"10","author":"Chun","year":"2022","journal-title":"Lancet Glob Health"},{"key":"ref42","first-page":"373","article-title":"Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients","volume-title":"AIDS","author":"Vandenhende","year":"2015"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/hiv.12124","article-title":"The significance of low-level viraemia in diverse settings: analysis of the treat Asia HIV observational database (TAHOD) and the Australian HIV observational database (AHOD)","volume":"15","author":"Kanapathipillai","year":"2014","journal-title":"HIV Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12879-022-07417-z","article-title":"Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-019-10884-9","article-title":"Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART","volume":"10","author":"Bachmann","year":"2019","journal-title":"Nat Commun"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciy989","article-title":"Persistent low-level viremia predicts subsequent Virologic failure: is it time to change the third 90?","volume":"69","author":"Esber","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e68174","DOI":"10.7554\/eLife.68174","article-title":"Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy","volume":"10","author":"Pasternak","year":"2021","journal-title":"eLife"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/sextrans-2024-056198","article-title":"Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis","volume":"100","author":"Za\u00e7e","year":"2024","journal-title":"Sex Transm Infect"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2325958220979817","DOI":"10.1177\/2325958220979817","article-title":"Low-level viremia predicts Virological failure in HIV-infected Omani patients receiving antiretroviral therapy","volume":"19","author":"Gaifer","year":"2020","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1080\/09540121.2020.1806198","article-title":"Low-level HIV viremia is associated with low antiretroviral prescription refill rates and social deprivation","volume":"33","author":"Goupil de Bouill\u00e9","year":"2021","journal-title":"AIDS Care"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/hiv.13568","article-title":"Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda","volume":"25","author":"Nanyeenya","year":"2024","journal-title":"HIV Med"},{"key":"ref52","article-title":"European AIDS clinical society guideline, version 12. 0","year":"2023"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1128\/AAC.00076-14","article-title":"Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients","volume":"58","author":"Ryscavage","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/AID.2019.0096","article-title":"Higher risks of virologic failure and all-cause deaths among older people living with HIV in Chongqing, China","volume":"35","author":"Wu","year":"2019","journal-title":"AIDS Res Hum Retrovir"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s13365-019-00728-z","article-title":"Pathogenesis of age-related HIV neurodegeneration","volume":"25","author":"Mackiewicz","year":"2019","journal-title":"J Neurovirol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/QAD.0000000000001824","article-title":"Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation","volume":"32","author":"Bull","year":"2018","journal-title":"AIDS"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/infdis\/jir208","article-title":"Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy","volume":"204","author":"Chun","year":"2011","journal-title":"J Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/hiv.13023","article-title":"Demographic and clinical factors associated with immune reconstitution in HIV\/HBV co-infected and HIV mono-infected patients: a retrospective cohort study","volume":"21","author":"Jiang","year":"2020","journal-title":"HIV Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","article-title":"Persistent low-level viremia in persons living with HIV undertreatment: An unresolved status","volume":"12","author":"Crespo-Bermejo","year":"2021","journal-title":"Virulence"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e0268540","DOI":"10.1371\/journal.pone.0268540","article-title":"Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: a Swedish observational study","volume":"17","author":"Brattg\u00e5rd","year":"2022","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e0142923","DOI":"10.1371\/journal.pone.0142923","article-title":"Factors associated with low-level viraemia and virological failure: results from the Austrian HIV cohort study","volume":"10","author":"Leierer","year":"2015","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3969\/j.issn.1671-8348.2015.16.016","article-title":"Analysis of antiviral treatment effects of AIDS patients with male-male sexual behavior in Chongqing","volume":"44","author":"Zhou","year":"2015","journal-title":"Chongqing Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jrsm.1704","article-title":"Meta-analyses of partial correlations are biased: detection and solutions","volume":"15","author":"Stanley","year":"2024","journal-title":"Res Synth Methods"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1661253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:31:40Z","timestamp":1759383100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1661253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":63,"alternative-id":["10.3389\/fpubh.2025.1661253"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1661253","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1661253"}}